Combining Clinical Parameters and Immunohistochemical Markers Might Strengthen Prediction of Recurrence of Non-Muscle Invasive Bladder Cancer

Similar Items

• A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers
  by: Jiangchuan Pi, et al.
  Published: (2022-05-01)
• The prognostic effect of immunohistochemical staining rates in patients with non–muscle-invasive bladder cancer
  by: Aykut Demirci, et al.
  Published: (2023-07-01)
• Efficacy evaluation of various immunohistochemical markers in stage definition and prognosis of muscle invasive urinary bladder cancer
  by: Ponukalin A.N., et al.
  Published: (2014-03-01)
• Expression of protease activating receptor-2 (PAR-2) is positively correlated with the recurrence of non-muscle invasive bladder cancer: an immunohistochemical analysis
  by: Nakahara K, et al.
  Published: (2019-04-01)
• Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers
  by: R. Vaithegi, et al.
  Published: (2025-01-01)